In recent trading session, Elanco Animal Health Inc (NYSE:ELAN) saw 0.75 million shares changing hands at last check today with its beta currently measuring 1.65. Company’s recent per share price level of $12.85 trading at -$0.03 or -0.23% at last check today assigns it a market valuation of $6.38B. That most recent trading price of ELAN’s stock is at a discount of -46.3% from its 52-week high price of $18.80 and is indicating a premium of 37.59% from its 52-week low price of $8.02. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 8.17 million shares which gives us an average trading volume of 5.68 million if we extend that period to 3-months.
For Elanco Animal Health Inc (ELAN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.81. Splitting up the data highlights that, out of 5 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Elanco Animal Health Inc (NYSE:ELAN) trade information
Upright in the red during last session for losing -0.23%, in the last five days ELAN remained trading in the green while hitting it’s week-highest on Tuesday, 05/13/25 when the stock touched $12.85 price level, adding 2.65% to its value on the day. Elanco Animal Health Inc’s shares saw a change of 6.11% in year-to-date performance and have moved 4.64% in past 5-day. Elanco Animal Health Inc (NYSE:ELAN) showed a performance of 55.95% in past 30-days. Number of shares sold short was 24.81 million shares which calculate 4.09 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 12 to the stock, which implies a fall of -7.08% to its recent value today. Analysts have been projecting 11 as a low price target for the stock while placing it at a high target of 18. It follows that stock’s current price would jump 14.4% in reaching the projected high whereas dropping to the targeted low would mean a gain of 14.4% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 29.95% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -8.68% while estimates for its earnings growth in next 5 years are of 5.91%.
Elanco Animal Health Inc (NYSE:ELAN)’s Major holders
Insiders are in possession of 1.03% of company’s total shares while institution are holding 103.74 percent of that, with stock having share float percentage of 104.82%. Investors also watch the number of corporate investors in a company very closely, which is 103.74% institutions for Elanco Animal Health Inc that are currently holding shares of the company. DODGE & COX is the top institutional holder at ELAN for having 83.58 million shares of worth $1.21 billion. And as of 2024-06-30, it was holding 16.9128 of the company’s outstanding shares.
The second largest institutional holder is PRIMECAP MANAGEMENT CO/CA/, which was holding about 52.8 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.6845 of outstanding shares, having a total worth of $761.94 million.
On the other hand, Dodge & Cox Funds-Dodge & Cox Stock Fund and VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 55.34 shares of worth $711.94 million or 11.14% of the total outstanding shares. The later fund manager was in possession of 18.98 shares on Dec 31, 2024 , making its stake of worth around $244.16 million in the company or a holder of 3.82% of company’s stock.
